Alastair Khodabukus et al.
Toxicological sciences : an official journal of the Society of Toxicology, 176(1), 124-136 (2020-04-16)
Traditional serum biomarkers used to assess skeletal muscle damage, such as activity of creatine kinase (CK), lack tissue specificity and sensitivity, hindering early detection of drug-induced myopathies. Recently, a novel four-factor skeletal muscle injury panel (MIP) of biomarkers consisting of